MicroRNAs Expression in Triple Negative vs Non Triple Negative Breast Cancer in Tunisia: Interaction With Clinical Outcome

PLoS ONE - United States
doi 10.1371/journal.pone.0111877
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

PD-L1 Expression in Triple-Negative Breast Cancer

Cancer immunology research
Cancer ResearchImmunology
2014English

Triple-Negative Breast Cancer

2018English

MiR-34b Is Associated With Clinical Outcome in Triple-Negative Breast Cancer Patients

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2012English

Dual Specificity Phosphatase 4 Gene Expression in Association With Triple-Negative Breast Cancer Outcome

Breast Cancer Research and Treatment
Cancer ResearchOncology
2014English

Transcriptomic Analyses Identify Key Differentially Expressed Genes and Clinical Outcomes Between Triple-Negative and Non-Triple-Negative Breast Cancer

Cancer Management and Research
Oncology
2018English

The Clinical Promise of Immunotherapy in Triple-Negative Breast Cancer

Cancer Management and Research
Oncology
2018English

FZD7 in Triple Negative Breast Cancer Cells

2011English

Triple Negative Breast Cancer: Breast Cancer Research in Evolution

Breast Disease
MedicineCancer ResearchOncology
2011English

Tumor Tissue microRNA Expression in Association With Triple-Negative Breast Cancer Outcomes

Breast Cancer Research and Treatment
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy